Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02367521 · ClinicalTrials.gov registry record · Phase 2
Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Depression & Other Neuropsychiatric Symptoms After Traumatic Brain Injury (TBI)
A Phase 2 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 2
- Development phase
- 70
- Enrollment target
NCT02367521: Completed Phase 2 study, sponsored by Johns Hopkins University.
NCT02367521 is a Phase 2 study that has completed, run by Johns Hopkins University. The registered enrollment target is 70 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02367521, a Phase 2 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 70 participants
- Enrollment target
Study Summary
Traumatic brain injury (TBI) is frequently complicated by depression and other problems such as post traumatic stress disorder (PTSD), sleep disturbance, cognitive deficits and behavioral problems. Untreated depression can lead to reduced productivity and poor global outcome. There is no Food and Drug Administration (FDA) approved drug for the treatment of TBI-related depression. The overarching goal of this small study is to determine the effectiveness of low frequency right (LFR) rTMS for the treatment of post-TBI depression and co-occurring psychiatric symptoms. Repetitive transcranial magnetic stimulation (rTMS) is a brain stimulation technique. It involves generating a brief magnetic field in a coil that is placed on the scalp. The magnetic field passes through the skull and induces a weak electrical current in the brain that briefly activates neural circuits at the stimulation site. Adults aged 18 and older, with a history of head injury of mild or moderate severity , who are currently experiencing symptoms of clinical depression may join the study.
Interventions
- COMBINATION_PRODUCT Low Frequency Right sided repetitive transcranial magnetic stimulation (LFR rTMS)
- DEVICE Sham Comparator: Sham Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2015-03 |
| Est. Completion | 2017-10-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02367521
The ClinicalTrials.gov registry entry for NCT02367521 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Low Frequency Right sided repetitive transcranial magnetic stimulation (LFR rTMS) is the first listed.
NCT02367521 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02367521 about?
NCT02367521 is a clinical study titled "Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Depression & Other Neuropsychiatric Symptoms After Traumatic Brain Injury (TBI)". Traumatic brain injury (TBI) is frequently complicated by depression and other problems such as post traumatic stress disorder (PTSD), sleep disturbance, cognitive deficits and behavioral problems. Untreated depression can lead to reduced productivity and poor global outcome. There is no Food and Dr...
What is the current status of trial NCT02367521?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 70 participants. The study started on 2015-03. Estimated completion is 2017-10-01.
What interventions are being tested in trial NCT02367521?
The interventions under investigation include: Low Frequency Right sided repetitive transcranial magnetic stimulation (LFR rTMS) (COMBINATION_PRODUCT), Sham Comparator: Sham Treatment (DEVICE).
Who is sponsoring clinical trial NCT02367521?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.